BlueRock Therapeutics Angeforderte Firma
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Weiterlesen
Being able to make an impact
Was ist das Beste an Ihrem Vergütungspaket?
The opportunity for Milestone bonuses
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
I'm local to our Cambridge site and appreciate the day to day interactions with folks outside of my team
Other Employee Reviews for BlueRock Therapeutics
×